
XLO Stock Price Prediction
Xilio Therapeutics Inc
Should I Buy Xilio Therapeutics Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XLO has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
XLO stock price ended at $0.8316 on Thursday, after rising 1.96%
The Xilio Therapeutics Inc stock price increased by 1.96% on the last trading day (06 Nov 2025), rising from 0.8022 to 0.8316. Throughout the last trading session, the stock experienced a fluctuation of 8.14% , ranging from a day low of $0.7842 to a day high of 0.848. The price has declined in 5 of the last 10 days, resulting in a total change of 7.57% during this period. On the last day, trading volume decrease by 266.93K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.42M shares were traded, amounting to approximately 1.14M.
XLO Technical Signals
XLO(Xilio Therapeutics Inc Corp) has 4 buy signals and 0 sell signals now. The current trend is an uptrend starting from 2025-10-23. The total price change during this trend is +7.57%. Recently, the price has increased while volume droped, indicating a potential warning signal. The average turnover of XLO over the last 5 trading days is 981.19K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
XLO Moving Average Analysis
Xilio Therapeutics Inc's overall moving average trend leans more bullish as of Friday, November 7, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $0.91, and $0.96. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.75, and $0.70. A break-down below any of these levels will issue sell signals.
XLO Short Selling Analysis
The short sale ratio of Xilio Therapeutics Inc(XLO) as of 05 Nov 2025 is 34.66%, dropping from last trading day. With decreasing price from 0.80 to 0.82. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary

Strong buy
Sell
0
Buy
4
Moving Average
Swing
Stock Price Above SMA_5
Short Term
SMA_5 Above SMA_20
Mid Term
SMA_20 Above SMA_60
Long Term
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.0162
Bullish
Momentum (10 days)
MOM_10 > 0
0.0585
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0123
Bullish
Moving Average
Price crosses above 250-day SMA
--
Bullish
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish

No Data
XLO Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Xilio Therapeutics Inc (XLO) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Xilio Therapeutics Inc Stock Forecast 2026
XLO Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Xilio Therapeutics Inc(XLO), our algorithm predicts XLO's 1-month price at $0.83, with an 4.37%upwardshift. Using a similarity score up to 90.11%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Xilio Therapeutics Inc (XLO.O) stock, as of Sunday, November 2, 2025 , forecasts a 4.37% change over the next month, based on its high correlation with IMAX.N stock patterns. The similarity between their price movements over the analyzed periods is 90.11%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

XLO
Future prediction
Up: 4.37%
Full Access. No Commitment.
7 Days Free!
AI Stock Picker
AI Swing Trade Signal
AI Earning Prediction
AI Screener
AI Financial Agent Help You Do Research
Already have an account? Sign In Here

IMAX
Up: 4.37%Similarity: 90.11%
Name
Similarity
Up/Down

IMAX.N
90.11%
+4.37%

CSBR.O
90.04%
-6.60%
XLO Seasonality Analysis
Based on XLO's historical stock price data across all years, the probability of a positive return in November is40.00%, suggesting it maynotbe an ideal month to invest in XLO. In contrast,Octoberoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Xilio Therapeutics Inc (XLO.O) stock in October has the highest probability of a positive return (75.00%), while March has the lowest probability (25.00%).
Performance Seasonality
The chart shows Xilio Therapeutics Inc. (XLO)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Xilio Therapeutics Inc (XLO.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XLO has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.









